Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020
BIS ruleTariff cut or exemptionFederal Register 08/04Open the original
Summary
The Bureau of Industry and Security reduces the tariff on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom from 10% to zero. The change applies to goods entered for consumption on or after 12:01 a.m. Eastern Time on July 31, 2026.
By industry
- Healthcare & Drug Pricing1 trading day−1.9%p15 stocks5 trading days+0.7%p15 stocks20 trading days+3.0%p15 stocks
“tariff rate on patented pharmaceuticals and associated pharmaceutical ingredients”
- Tariffs & Reshoring1 trading day+3.6%p15 stocks5 trading days+6.7%p15 stocks20 trading days−1.5%p15 stocks
“deleting ``+10%'' in each place that it appears and inserting ``+0%''”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 26/08/03 | 0.0% | 0.0% |
| 26/08/04 | +0.0% | +1.9% |
| 26/08/05 | +1.1% | +1.8% |
| 26/08/06 | +1.1% | +1.4% |
| 26/08/07 | +1.7% | +2.0% |
| 26/08/10 | +2.6% | +1.9% |
| 26/08/11 | +2.3% | +1.7% |
| 26/08/12 | +2.0% | +1.9% |
| 26/08/13 | +2.1% | +2.6% |
| 26/08/14 | +2.4% | +2.4% |
| 26/08/17 | +1.9% | +1.9% |
| 26/08/18 | +3.6% | +1.2% |
| 26/08/19 | +5.7% | +1.6% |
| 26/08/20 | +3.8% | +0.7% |
| 26/08/21 | +5.2% | +1.0% |
| 26/08/24 | +5.8% | +0.8% |
| 26/08/25 | +6.7% | +1.0% |
| 26/08/26 | +6.1% | +1.6% |
| 26/08/27 | +4.8% | +1.6% |
| 26/08/28 | +4.4% | +1.5% |
| 26/08/31 | +4.3% | +1.2% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
- Hyundai Steel 004020
- POSCO Holdings 005490
- SeAH Steel Holdings 003030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Sheldon Whitehouse
Partial saleAmgen
Partial saleAmgen
AMGN
$1K–$15K
Spouse
$1K–$15K
Reported 09/02
Traded 08/12
- Thomas H. Kean Jr.
Partial saleJohnson & Johnson
Partial saleJohnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 09/12
Traded 08/27
- John Boozman
Partial saleJohnson & Johnson
Partial saleJohnson & Johnson
JNJ
$1K–$15K
Joint
$1K–$15K
Reported 09/11
Traded 08/20
- Rick Larsen
BuyMcKesson
BuyMcKesson
MCK
$1K–$15K
Self
$1K–$15K
Reported 07/12
Traded 07/08
- David Taylor
Full saleAmgen
Full saleAmgen
AMGN
$1K–$15K
Self
$1K–$15K
Reported 09/05
Traded 08/26
- David Taylor
Full saleAmgen
Full saleAmgen
AMGN
$1K–$15K
Self
$1K–$15K
Reported 09/05
Traded 08/26
- Dan Newhouse
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$1K–$15K
Spouse
$1K–$15K
Reported 07/17
Traded 07/10
- Maria Salazar
BuyMerck
BuyMerck
MRK
$15K–$50K
Self
$15K–$50K
Reported 09/09
Traded 08/19
- Maria Salazar
BuyMerck
BuyMerck
MRK
$15K–$50K
Self
$15K–$50K
Reported 09/09
Traded 08/19
- Dan Newhouse
Partial saleELI Lilly
Partial saleELI Lilly
LLY
$1K–$15K
Spouse
$1K–$15K
Reported 07/17
Traded 07/10